Source: Annual Congress 2011 - Monitoring with lung function tests in airway diseases
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Z. Podolec (Kracow, Poland). Freeflowmetry – The new method of evaluation of the respiratory function phenotype. Eur Respir J 2011; 38: Suppl. 55, 933

Member's Comments

No comment yet.

Related content which might interest you: Freeflowmetry – The proposal of the new method of evaluation of the respiratory function phenotype Source: Annual Congress 2010 - Advances in lung function II Year: 2010 LungPoint® – A new approach to peripheral lung lesions Source: Annual Congress 2010 - Tissue is mostly the issue: diagnostic and therapeutic bronchoscopy Year: 2010 Airway resistances: Raw, sRaw, sReff – Which is the best determinant of airway function? Source: Annual Congress 2010 - Lung function from infancy to adulthood Year: 2010 Triple 0 – A new respiratory syndrome? Source: Annual Congress 2012 - Advanced experience with long-term noninvasive ventilation and late-breaking abstracts Year: 2012 A simplified physiological scoring system for predicting severity in community acquired pneumonia – an international derivation and validation study Source: Annual Congress 2009 - Assessment of severity in respiratory infections: severity scales and biomarkers Year: 2009 Why are we so poor at following guidelines? – A detailed analysis of a bronchiolitis pathway and its implementation Source: Annual Congress 2010 - Paediatric epidemiology: infection, prematurity and congenital abnormalities Year: 2010 Halotherapy – A possible method to enhance airway treatment on patients with obstructive pathology Source: Annual Congress 2012 - Treatment of asthma, bronchiectasis and cough: inhaler use Year: 2012 Cardiorespiratory system dysfunction (CRSD) scale – indications for invasive monitoring and prognosis tool Source: Annual Congress 2009 - Lung infections; diagnostic and therapeutic problems Year: 2009 6-minute-walk in lung cancer – a new predictor for response and the performance status? Source: Annual Congress 2009 - Various diagnostic aspects in lung cancer and rare lung tumours Year: 2009 Evaluation of a new motion sensor in patients with COPD – Preliminary results Source: Annual Congress 2010 - Physical activity methodology assessment and clinical consequences Year: 2010 Evaluation of difficult asthma – a single centre experience Source: Annual Congress 2009 - Towards improving asthma control Year: 2009 Impaired pulmonary function and the risk of tuberculosis – A population based cohort study Source: Annual Congress 2012 - Tuberculosis: epidemiological and public health features Year: 2012 Ways to shorten the lung clearance index measurement ΙΙ – How long to wash? Source: Annual Congress 2012 - New developments in paediatric respiratory physiology Year: 2012 Respiratory muscle function during and after a severe exacerbation of COPD – Preliminary results Source: Annual Congress 2011 - Respiratory physiotherapy in the intensive care unit and on the ward: breathing exercises and respiratory muscles Year: 2011 T spot TB reactivity – ²to treat or not to treat² Source: Annual Congress 2009 - Clinical immunology of tuberculosis Year: 2009 Ways to shorten the lung clearance index measurement I – Are three measurements needed? Source: Annual Congress 2012 - New understanding of childhood lung disease through physiological measurement Year: 2012 The results of drug resistance survey of MDR-strains on second line drugs obtains in national reference laboratory – " M.Nasta " Institute – Bucharest Source: Annual Congress 2011 - Epidemiology of multidrug-resistant and extensively drug-resistant tuberculosis Year: 2011 Scoring systems for estimation of severity community acquired pneumonia – our impressions Source: Annual Congress 2009 - Assessment of severity in respiratory infections: severity scales and biomarkers Year: 2009 Sensitivity and specificity of airway hyperreactivity (AHR) based on methacholine challenge (MCH) tests – Comparison of sGeff with FEV1 and MEF50 as target parameter Source: Annual Congress 2012 - Bronchial challenge as a biomarker of respiratory disease Year: 2012 BAMBI – A TGF-β pseudoreceptor with possible functional involvement in COPD and NTHI infection Source: Annual Congress 2011 - Molecular: pathology of infectious and inflammatory lung disease Year: 2011